Auranofin
Generic name: Auranofin
Brand names: Ridaura
Dosage form: oral capsule (3 mg)
Drug class:
Antirheumatics
Usage of Auranofin
Auranofin is a form of gold that reduces some of the effects of the inflammatory process in the body.
Auranofin is used to treat rheumatoid arthritis (RA) in adults.
Auranofin is usually given only to people unable to use other RA medications, or when other treatments did not work or have stopped working.
Auranofin will not reverse any cartilage or joint damage that has already occurred in your body.
Auranofin may also be used for other purposes not listed in this medication guide.
Auranofin side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Auranofin may cause serious side effects. Call your doctor at once if you have:
Auranofin may cause more side effects on the stomach than gold injections cause. If you were switched from gold injections to auranofin capsules, tell your doctor if you have concerns about these side effects. You may need to use auranofin for a few months before your symptoms improve.
Common side effects of auranofin may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Auranofin
You should not use auranofin if you are allergic to it, or if you have ever had medical problems caused by using gold therapy, such as:
Tell your doctor if you have ever had:
It is not known whether auranofin will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
You should not breastfeed while using auranofin.
Auranofin is not approved for use by anyone younger than 18 years old.
Relate drugs
- Apremilast
- Auranofin
- Cuprimine
- Depen
- D-Penamine
- Otezla
- Penicillamine
- Ridaura
- Rinvoq
- Tofacitinib
- Upadacitinib
- Xeljanz
How to use Auranofin
Usual Adult Dose for Rheumatoid Arthritis:
3 mg orally 2 times a day OR 6 mg orally once a day; if response is inadequate after 6 months, increase to 3 mg orally 3 times a day; discontinue therapy if response is inadequate after 3 months at 9 mg/dayComments:-Therapy should not be initiated at doses exceeding 6 mg daily because it is associated with an increased incidence of diarrhea.-This drug should be added to a comprehensive program, including nondrug therapies.-This drug does not produce an immediate response. Therapeutic effects may be seen after 3 to 4 months, although improvement has not been seen in some patients before 6 months.-Gold cannot reverse structural damage to joints caused by previous disease. The greatest potential benefit occurs in patients with active synovitis, particularly in its early stage.Use: For active classical or definite rheumatoid arthritis patients who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs
Warnings
You should not use auranofin if you have ever had a severe reaction to gold therapy that affected your skin, lungs, bone marrow, blood cells, or your stomach or intestines.
Auranofin contains gold, which may be toxic and can cause symptoms such as rash, itching, mouth sores, or blood in your urine, or severe diarrhea.
Call your doctor at once if you have a severe skin rash or itching, mouth sores, severe diarrhea, pale skin, unusual tiredness, easy bruising or bleeding, blood in your urine or stools, or if you cough up blood.
What other drugs will affect Auranofin
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may affect auranofin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions